BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 17962357)

  • 1. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice.
    Kjellev S; Haase C; Lundsgaard D; Ursø B; Tornehave D; Markholst H
    Eur J Immunol; 2007 May; 37(5):1397-406. PubMed ID: 17407193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorating effect of saporin-conjugated anti-CD11b monoclonal antibody in a murine T-cell-mediated chronic colitis.
    Kanai T; Uraushihara K; Totsuka T; Nemoto Y; Fujii R; Kawamura T; Makita S; Sawada D; Yagita H; Okumura K; Watanabe M
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1136-42. PubMed ID: 16824065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
    Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
    Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
    Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
    J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis.
    Totsuka T; Kanai T; Uraushihara K; Iiyama R; Yamazaki M; Akiba H; Yagita H; Okumura K; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G595-603. PubMed ID: 12631559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
    Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
    Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.
    Aranda R; Sydora BC; McAllister PL; Binder SW; Yang HY; Targan SR; Kronenberg M
    J Immunol; 1997 Apr; 158(7):3464-73. PubMed ID: 9120308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
    Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
    Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
    Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
    Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner.
    Noguchi D; Wakita D; Tajima M; Ashino S; Iwakura Y; Zhang Y; Chamoto K; Kitamura H; Nishimura T
    Int Immunol; 2007 Dec; 19(12):1431-40. PubMed ID: 17981790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue specificity of E- and P-selectin ligands in Th1-mediated chronic inflammation.
    Chu A; Hong K; Berg EL; Ehrhardt RO
    J Immunol; 1999 Nov; 163(9):5086-93. PubMed ID: 10528215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.